End-to-end preclinical trial management on a single software platform, Pristima XD, for a large Gene Therapy Lab

January 19, 2021 – This Xybion client is one of the world’s most powerful research and teaching institutions, and one of the top recipients of NIH funding in the US. They focus on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Their Gene Therapy Program has decided to partner with Xybion to implement the gold standard preclinical digital lab execution system (Pristima XD) to manage their studies end-to-end through a single software platform. They conduct end-to-end drug discovery and preclinical studies. The lab process execution and data management are a critical part of their research, and the digitized processes will make GLP studies more efficient, improve compliance with regulatory needs and help manage intellectual assets better.